RecruitingNCT06374719

WiTNNess - TNNT1 Myopathy Natural History Study

WiTNNess: An International Natural History Study of Autosomal Recessive TNNT1 Myopathy


Sponsor

Clinic for Special Children

Enrollment

40 participants

Start Date

Sep 23, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

WiTNNess is designed to accurately document the natural course and variation of muscle disease caused by pathogenic changes of the TNNT1 gene. The primary aim of the study is to specify meaningful outcome measures for future clinical trials. WiTNNess is open to children and adults worldwide. Participants can choose to include their information once (cross-sectional cohort) or every few months (prospective cohort).


Eligibility

Inclusion Criteria2

  • Diagnosed with biallelic pathogenic variants of TNNT1
  • Infantile-onset or childhood-onset proximal weakness without confounding medical conditions that could effect muscle health.

Exclusion Criteria1

  • Another known or suspected medical condition (genetic or acquired) that could potentially alter the natural disease course or otherwise interfere with completion of study procedures.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Clinic for Special Children

Gordonville, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06374719


Related Trials